Brief: Liminal Biosciences Reports Q2 Revenues Were $0.5 Mln Vs $0.8 Mln in Q2 2019

Liminal BioSciences

10/08/2020 22:07

Aug 10 (Reuters) - Liminal BioSciences Inc  LMNL.O :
    * LIMINAL BIOSCIENCES REPORTS FINANCIAL RESULTS FOR Q2-2020
    * LIMINAL BIOSCIENCES - REVENUES WERE $0.5 MILLION FOR THE
SECOND
QUARTER OF 2020, AS COMPARED TO $0.8 MILLION FOR THE SECOND
QUARTER OF 2019
    * LIMINAL BIOSCIENCES INC - EXPECTED RESUBMISSION OF BLA FOR
RYPLAZIM IN Q3-2020
    * LIMINAL BIOSCIENCES INC - EXPECTED PDUFA DATE FOR RYPLAZIM
IN
Q12021

Source text for Eikon:  ID:nCNWf4LhDa 
Further company coverage:  LMNL.O 

 ((Reuters.Briefs@thomsonreuters.com;))